Sanofi expands patient affordability program by offering access to all its insulins for $35 per month in the US
On Sept. 26, 2025, Sanofi US announced a broad expansion of its Insulins Valyou Savings Program by offering…
-
-
Amgen Announces $650 Million Manufacturing Expansion in Puerto Rico
On Sept. 26, 2025, Amgen announced a $650 million expansion of its U.S. manufacturing network in Puerto Rico,…
-
Lilly and Alexandria Real Estate opens Gateway Labs site in San Diego to boost local biotechnology ecosystem
On Sept. 26, 2025,Eli Lilly and announced the official opening of its newest Lilly Gateway Labs (LGL) site…
-
Artificial Intelligence | Biotechnology | Environmental | EPA | Genomics | Marine Science | Medical Device | Medicine | Nanotechnology | Non-Profit Research | Radiology | U.S. Congress
Pacific Northwest National Laboratory lays off 68 Employees
On Sept. 25, 2025, the operator of Pacific Northwest National Laboratory laid off 68 employees effective November 18, saying “unforeseen business circumstances” meant it wasn’t able to provide…
-
Biotechnology | Diagnostics | Disease | Neurology | NIH
NIH establishes nation’s first dedicated organoid development center to reduce reliance on animal modeling
On Sept. 25, 2025, the National Institutes of Health (NIH) announced the award of contracts for launching the…
-
CIRM approves $73 million in awards for discovery research
On Sept. 25, 2025, The California Institute for Regenerative Medicine (CIRM) has approved awarding more than $73 million…
-
Final Landmark Clinical Trial Data Demonstrates Deep, Durable Responses to Menin Inhibition in Acute Leukemia Patients
On Sept. 25, 2025, Final data from a landmark clinical trial in patients with an aggressive form of…
-
Glaukos Breaks Ground on New Research, Development, and Manufacturing Facility in Huntsville, Alabama
On Sept. 25, 2025, Glaukos, an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the…
-
Biolinq Shine™ Granted De Novo Classification by U.S. FDA for the First Fully Autonomous, Needle-Free Glucose Sensor
On Sept. 25, 2025, Biolinq, a pioneering developer of precision multi-analyte biosensors to improve metabolic health, announced the…
-
Cloned Black-footed Ferret Kits Offer Hope for the Species
On Sept. 24, 2025, the U.S. Fish and Wildlife Service (USFWS) in collaboration with partners, announced the birth…
-
Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation
On Sept. 24, 2025, Sanofi Ventures has announced an additional $625 million multi-year capital commitment from Sanofi, increasing…
-
Gene therapy appears to slow Huntington’s disease progression
On Sept. 24, 2025, a global clinical trial for a new Huntington’s disease treatment has posted positive results,…
-
Biodiversity Cell Atlas: mapping the tree of life at cellular resolution
On Sept. 24, 2025, an ambitious and revolutionary initiative aims to map every cell of all eukaryotic life…
-
Biotechnology | HIV | Vaccine | WHO
Indian drugmakers Dr. Reddy’s, Hetero to sell generic HIV prevention drug for $40 a year
On Sept. 24, 2025, Indian drugmakers Dr Reddy’s Laboratories and Hetero Labs announced they will sell generic versions…
-
Lilly plans to build a new $6.5 billion facility to manufacture active pharmaceutical ingredients in Texas
On Sept. 23, 2025, Eli Lilly announced that it plans to build a new $6.5 billion manufacturing facility…
-
Variational AI Enters $349 Million Collaboration with Merck to Apply Generative AI to Drug Discovery
On Sept. 23, 2025, Variational AI a generative AI drug discovery company, announced a collaboration with Merck to…
-
Pfizer to Acquire Metsera and its Next-Generation Obesity Portfolio for $4.9 billion
On Sept. 22, 2025, Pfizer and Metsera announced the companies have entered into a definitive agreement under which…
-
Bill Gates pledges $912 million to global disease fight, urges governments to step up
On Sept. 22, 2025, The Gates Foundation will give $912 million to the Global Fund to Fight AIDS,…
-
FDA Takes Action to Make a Treatment Available for Autism Symptoms
On Sept. 22, 2025, the U.S. Food and Drug Administration (FDA) announced it h initiated the approval of…
-
Celltrion unit pays $330 million for Eli Lilly production facility, filing shows
On Sept. 22, 2025, Celltrion said in a regulatory filing in South Korea its U.S. subsidiary has acquired…
-
Over 400,000 turkeys euthanized in South Dakota due to bird flu
On Sept. 22, 2025, the U.S. Department of Agriculture (USDA) reported that over 400,000 turkeys have been euthanized…
-
Mexico Confirms Case of New World Screwworm in Nuevo Leon
On Sept. 21, 2025, Mexico’s National Service of Agro-Alimentary Health, Safety, and Quality (SENASICA) confirmed a new case…
-
Biotechnology | CDC | COVID-19 | Diagnostics | Genomics | Infectious Disease | Measles | NIH | Polio | Vaccine | Women's Health
CDPH and West Coast Health Alliance Release Statement Responding to ACIP Updates to National Vaccine Recommendations
On Sept. 19, 2025, the state health officials of the members of the West Coast Health Alliance, including…
-
Biotechnology | CDC | COVID-19 | Infectious Disease | NIH | Vaccine
Kennedy’s vaccine advisers change COVID shot guidance, calling them an individual choice
On Sept. 19, 2025, Health Secretary Robert F. Kennedy Jr.’s new vaccine advisers added confusion to this fall’s…
-
The tale of the creature with the most chromosomes
On Sept. 19, 2025, researchers at the Wellcome Sanger Institute and the Institute of Evolutionary Biology, Barcelona reported…
-
Biogen to Acquire Alcyone Therapeutics for $85 million, Expanding Drug Delivery Solution Portfolio
On Sept. 18, 2025, Biogen announced it has has entered into a definitive agreement to acquire Massachusetts-based Alcyone…
-
Biogen Receives EC Approval for ZURZUVAE® (zuranolone), the First and Only Treatment Approved for Women with Postpartum Depression in Europe
On Sept. 17, 2025, Biogen announced that the European Commission (EC) has granted marketing authorization for ZURZUVAE® (zuranolone)…
-
Roche to acquire 89bio, and its phase 3 FGF21 analog for the therapy of moderate to severe MASH for US $3.5 billion
On Sept. 17, 2025, Roche announced that it has entered into a definitive merger agreement to acquire 89bio,…
-
GSK to invest $30 billion in R&D and Manufacturing in the U.S. over next 5 years
On Sept. 17, 2025, GSK announced plans to invest $30 billion across the United States in research and…
-
Novo Nordisk’s oral semaglutide 25 mg (Wegovy® in a pill) delivered 16.6% weight loss in people with obesity in a newly published study
On Sept. 17, 2025, The New England Journal of Medicine published the results from the OASIS 4 phase…
